Indoor tanning bed use and risk of food addiction based on the modified Yale Food Addiction Scale

Abstract

The popularity of indoor tanning may be partly attributed to the addictive characteristics of tanning for some individuals. We aimed to determine the association between frequent indoor tanning, which we view as a surrogate for tanning addiction, and food addiction. A total of 67,910 women were included from the Nurses’ Health Study II. In 2005, we collected information on indoor tanning during high school/college and age 25-35 years, and calculated the average use of indoor tanning during these periods. Food addiction was defined as ≥3 clinically significant symptoms plus clinically significant impairment or distress, assessed in 2009 using a modified version of the Yale Food Addiction Scale. Totally 23.3% (15,822) of the participants reported indoor tanning at high school/college or age 25-35 years. A total of 5,557 (8.2%) women met the criteria for food addiction. We observed a dose–response relationship between frequency of indoor tanning and the likelihood of food addiction (P_trend<0.0001), independent of depression, BMI, and other confounders. Compared with never indoor tanners, the odds ratio (95% confidence interval) of food addiction was 1.07 (0.99-1.17) for average indoor tanning 1-2 times/year, 1.25 (1.09-1.43) for 3-5 times/year, 1.34 (1.14-1.56) for 6-11 times/year, 1.61 (1.35-1.91) for 12-23 times/year, and 2.98 (1.95-4.57) for 24 or more times/year. Frequent indoor tanning before or at early adulthood is associated with prevalence of food addiction at middle age. Our data support the addictive property of frequent indoor tanning, which may guide intervention strategies to curb indoor tanning and prevent skin cancer.

Keywords

indoor tanning / food addiction / cohort study / skin cancer / epidemiology / UV radiation

References

[1] Fell GL, Robinson KC, Mao J, Skin β-endorphin mediates addiction to UV light[J]. Cell, 2014, 157(7): 1527–1534

[2] Fisher DE, James WD. Indoor tanning—science, behavior, and policy[J]. N Engl J Med, 2010, 363(10): 901–903

[3] Weinstock MA, Fisher DE. Indoor ultraviolet tanning: what the data do and do not show regarding risk of melanoma and keratinocyte malignancies[J]. J Natl Compr Canc Netw, 2010, 8(8): 867–872., quiz 873

[4] Zhang M, Qureshi AA, Geller AC, Use of tanning beds and incidence of skin cancer[J]. J Clin Oncol, 2012, 30(14): 1588–1593

[5] Heckman CJ, Cohen-Filipic J, Darlow S, Psychiatric and addictive symptoms of young adult female indoor tanners[J]. Am J Health Promot, 2014, 28(3): 168–174

[6] Boniol M, Autier P, Boyle P, Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis[J]. BMJ, 2012, 345: e4757

[7] Wehner MR, Chren MM, Nameth D, International prevalence of indoor tanning: a systematic review and meta-analysis[J]. JAMA Dermatol, 2014, 150(4): 390–400

[8] Wehner MR, Shive ML, Chren MM, Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis[J]. BMJ, 2012, 345: e5909

[9] Albert MR, Ostheimer KG. The evolution of current medical and popular attitudes toward ultraviolet light exposure: part 1[J]. J Am Acad Dermatol, 2002, 47(6): 930–937

[10] Mosher CE, Danoff-Burg S. Addiction to indoor tanning: relation to anxiety, depression, and substance use[J]. Arch Dermatol, 2010, 146(4): 412–417

[11] Grange F, Mortier L, Crine A, Prevalence of sunbed use, and characteristics and knowledge of sunbed users: results from the French population-based Edifice Melanoma survey[J]. J Eur Acad Dermatol Venereol, 2015, 29(Suppl 2): 23–30

[12] Schneider S, Diehl K, Bock C, Sunbed use, user characteristics, and motivations for tanning: results from the German population-based SUN-Study 2012[J]. JAMA Dermatol, 2013, 149(1): 43–49

[13] Cartmel B, Dewan A, Ferrucci LM, Novel gene identified in an exome-wide association study of tanning dependence[J]. Exp Dermatol, 2014, 23(10): 757–759

[14] Dallman MF, Pecoraro N, Akana SF, Chronic stress and obesity: a new view of “comfort food”[J]. Proc Natl Acad Sci USA, 2003, 100(20): 11696–11701

[15] Rowland NE, Antelman SM. Stress-induced hyperphagia and obesity in rats: a possible model for understanding human obesity[J]. Science, 1976, 191(4224): 310–312

[16] Corwin RL, Avena NM, Boggiano MM. Feeding and reward: perspectives from three rat models of binge eating[J]. Physiol Behav, 2011, 104(1): 87–97

[17] Gearhardt AN, Grilo CM, DiLeone RJ, Can food be addictive? Public health and policy implications[J]. Addiction, 2011, 106(7): 1208–1212

[18] Davis C, Curtis C, Levitan RD, Evidence that ‘food addiction’ is a valid phenotype of obesity[J]. Appetite, 2011, 57(3): 711–717

[19] Davis C. Evolutionary and neuropsychological perspectives on addictive behaviors and addictive substances: relevance to the “food addiction” construct[J]. Subst Abuse Rehabil, 2014, 5: 129–137

[20] Cota D, Tschöp MH, Horvath TL, Cannabinoids, opioids and eating behavior: the molecular face of hedonism[J]? Brain Res Rev, 2006, 51(1): 85–107

[21] Ulrich-Lai YM, Christiansen AM, Ostrander MM, Pleasurable behaviors reduce stress via brain reward pathways[J]. Proc Natl Acad Sci U S A, 2010, 107(47): 20529–20534

[22] Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats[J]. Nat Neurosci, 2010, 13(5): 635–641

[23] Parylak SL, Koob GF, Zorrilla EP. The dark side of food addiction[J]. Physiol Behav, 2011, 104(1): 149–156

[24] Morley JE, Blundell JE. The neurobiological basis of eating disorders: some formulations[J]. Biol Psychiatry, 1988, 23(1): 53–78

[25] Monteleone P. New frontiers in endocrinology of eating disorders[J]. Curr Top Behav Neurosci, 2011, 6: 189–208

[26] Reece AS. Hypothalamic opioid-melanocortin appetitive balance and addictive craving[J]. Med Hypotheses, 2011, 76(1): 132–137

[27] Grant JE, Chamberlain SR. Impulsive action and impulsive choice across substance and behavioral addictions: cause or consequence[J]? Addict Behav, 2014, 39(11): 1632–1639

[28] Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes[J]. Nat Rev Genet, 2005, 6(7): 521–532

[29] Flint AJ, Gearhardt AN, Corbin WR, Food-addiction scale measurement in 2 cohorts of middle-aged and older women[J]. Am J Clin Nutr, 2014, 99(3): 578–586

[30] Cartmel B, Ferrucci LM, Spain P, Indoor tanning and tanning dependence in young people after a diagnosis of basal cell carcinoma[J]. JAMA Dermatol, 2013, 149(9): 1110–1111

[31] Mayer D, Layman A, Carlson J. Sun-protection behaviors of melanoma survivors[J]. J Am Acad Dermatol, 2012, 66(1): e9–e10

[32] Chen AM, Vazquez E, Courquin J, Tobacco use among long-term survivors of head and neck cancer treated with radiation therapy[J]. Psychooncology, 2014, 23(2): 190–194

[33] Barfield ET, Moser VA, Hand A, b-endorphin modulates the effect of stress on novelty-suppressed feeding[J]. Front Behav Neurosci, 2013, 7: 19

[34] Parikh D, Hamid A, Friedman TC, Stress-induced analgesia and endogenous opioid peptides: the importance of stress duration[J]. Eur J Pharmacol, 2011, 650(2-3): 563–567

[35] Grisel JE, Bartels JL, Allen SA, Influence of beta-Endorphin on anxious behavior in mice: interaction with EtOH[J]. Psychopharmacology (Berl), 2008, 200(1): 105–115

[36] Govantes C, Marín J. Effect of angiotensin converting enzyme inhibitors on quality of life in hypertensive patients. Pharmacodynamic basis[J]. Fundam Clin Pharmacol, 1996, 10(4): 400–405

[37] Handa K, Sasaki J, Tanaka H, Effects of captopril on opioid peptides during exercise and quality of life in normal subjects[J]. Am Heart J, 1991, 122(5): 1389–1394

[38] Bond C, LaForge KS, Tian M, Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction[J]. Proc Natl Acad Sci USA, 1998, 95(16): 9608–9613

[39] Zhou Y, Kreek MJ. Persistent increases in rat hypothalamic POMC gene expression following chronic withdrawal from chronic “binge” pattern escalating-dose, but not steady-dose, cocaine[J]. Neuroscience, 2015, 289: 63–70

[40] Zalewska-Kaszubska J, Bajer B, Gorska D, Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with lamotrigine[J]. Physiol Behav, 2015, 139: 7–12

[41] Dawson DA, Goldstein RB, Chou SP, Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders[J]. Alcohol Clin Exp Res, 2008, 32(12): 2149–2160

[42] Casey BJ, Jones RM. Neurobiology of the adolescent brain and behavior: implications for substance use disorders[J]. J Am Acad Child Adolesc Psychiatry, 2010, 49(12): 1189–1201., quiz 1285

[43] Cui R, Widlund HR, Feige E, Central role of p53 in the suntan response and pathologic hyperpigmentation[J]. Cell, 2007, 128(5): 853–864

[44] Nelson EC, Lynskey MT, Heath AC, ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure[J]. JAMA Psychiatry, 2013, 70(3): 325–333

[45] Spadola CE, Wagner EF, Dillon FR, Alcohol and drug use among postoperative bariatric patients: a systematic review of the emerging research and its implications[J]. Alcohol Clin Exp Res, 2015, 39(9): 1582–1601

[46] Kutlu MG, Parikh V, Gould TJ. Nicotine addiction and psychiatric disorders[J]. Int Rev Neurobiol, 2015, 124: 171–208

Acknowledgments

The work was supported by Brown University Richard B. Salomon Faculty Research Award, Research Career Development Award of Dermatology Foundation, and Nurses’ Health Study II grant (UM1 CA176726). We would like to thank the participants and staff of the Nurses' Health Study II, for their valuable contributions as well as the following state cancer registries for their help: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, and WY. The authors assume full responsibility for analyses and interpretation of these data. The views presented in this manuscript do not necessarily represent the views of the Department of Veteran Affairs. The authors have no competing interests or financial relationships to disclose.

RIGHTS & PERMISSIONS

2017 2017 by the Journal of Biomedical Research. All rights reserved